In March 2025, the company declared new programs for a immediate-to-buyer offering of its Wegovy weight loss drug. The company proven a new pharmacy, called NovoCare, which would charge prospects $499 per 30 days for access to the drug, below fifty percent the cost of the drug through other pharmaceutical distribution networks.[fifty three]At the c